INS and polycystic ovary syndrome: Four months of daily pioglitazone treatment (30 mg) increased insulin-stimulated Rd (at similar steady-state insulin concentrations to this study) by 14% in IGT patients [32], while six months of daily pioglitazone treatment (45 mg) increased it by 28% in IGT patients with polycystic ovary syndrome [31].